av/astrazeneca--big.svg

LSE:AZN

AstraZeneca plc

  • Stock

GBP

Last Close

9,725.00

08/11 16:50

Market Cap

1.88B

Beta: 0.17

Volume Today

4.07M

Avg: 2.39M

PE Ratio

34.12

PFCF: 28.86

Dividend Yield

1.81%

Payout:75.97%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
25.71B
-
26.09B
1.49%
24.71B
5.32%
23.00B
6.90%
22.46B
2.33%
22.09B
1.67%
24.38B
10.38%
26.62B
9.16%
37.42B
40.58%
44.35B
18.53%
45.81B
3.29%
cost of revenue
5.26B
-
5.84B
11.04%
4.65B
20.47%
4.13B
11.19%
4.32B
4.65%
4.94B
14.31%
4.92B
0.30%
5.30B
7.68%
12.44B
134.70%
12.39B
0.37%
8.27B
33.27%
gross profit
20.45B
-
20.25B
0.96%
20.06B
0.94%
18.88B
5.91%
18.15B
3.86%
17.15B
5.47%
19.46B
13.46%
21.32B
9.53%
24.98B
17.18%
31.96B
27.94%
37.54B
17.47%
selling and marketing expenses
12.51B
-
13.32B
6.49%
11.45B
14.06%
9.74B
14.95%
10.54B
8.26%
10.36B
1.72%
11.85B
14.34%
11.69B
1.31%
15.68B
34.10%
18.95B
20.89%
18.22B
3.87%
general and administrative expenses
12.21B
-
13B
6.50%
11.11B
14.52%
9.41B
15.29%
10.23B
8.71%
selling general and administrative expenses
12.51B
-
13.32B
6.49%
11.45B
14.06%
9.74B
14.95%
10.54B
8.26%
10.36B
1.72%
11.85B
14.34%
11.69B
1.31%
15.68B
34.10%
18.95B
20.89%
18.22B
3.87%
research and development expenses
4.82B
-
5.58B
15.72%
6.00B
7.49%
5.89B
1.78%
5.76B
2.26%
5.93B
3.04%
5.96B
0.44%
5.99B
0.55%
9.74B
62.51%
9.76B
0.27%
10.94B
12.02%
other expenses
-12.77B
-
-13.76B
7.73%
-11.63B
15.45%
-9.74B
16.27%
-10.44B
7.19%
-650M
93.77%
-1.54B
137.08%
-1.53B
0.84%
-1.49B
2.36%
-514M
65.55%
cost and expenses
22.00B
-
23.96B
8.90%
20.59B
14.04%
18.10B
12.11%
18.79B
3.80%
18.70B
0.45%
21.19B
13.28%
21.45B
1.27%
36.36B
69.48%
40.59B
11.64%
37.09B
8.63%
operating expenses
16.74B
-
18.12B
8.23%
15.95B
11.97%
13.97B
12.38%
14.47B
3.55%
13.77B
4.86%
16.27B
18.14%
16.16B
0.67%
23.92B
48.08%
28.20B
17.89%
28.82B
2.19%
interest expense
495M
-
963M
94.55%
1.07B
11.63%
1.38B
28.74%
1.51B
8.96%
1.42B
5.90%
1.43B
0.92%
1.31B
8.80%
1.30B
0.46%
1.35B
3.54%
1.59B
18.05%
ebitda
8.35B
-
5.49B
34.20%
7.00B
27.41%
7.29B
4.25%
6.77B
7.16%
7.17B
5.82%
7.02B
2.08%
8.37B
19.31%
7.57B
9.63%
9.33B
23.29%
13.91B
49.15%
operating income
3.71B
-
2.14B
42.43%
4.11B
92.51%
4.90B
19.15%
3.68B
24.99%
3.39B
7.89%
2.92B
13.67%
5.16B
76.54%
1.06B
79.54%
3.76B
255.78%
8.19B
118.07%
depreciation and amortization
4.58B
-
3.28B
28.39%
2.85B
13.10%
2.36B
17.36%
3.04B
28.81%
3.75B
23.62%
4.09B
9.03%
3.21B
21.58%
6.51B
102.84%
5.57B
14.43%
4.93B
11.42%
total other income expenses net
-412M
-
-859M
108.50%
-63M
92.67%
-20M
68.25%
-65M
225%
483M
843.08%
-1.38B
384.89%
-1.25B
9.45%
-1.32B
6.02%
-1.26B
4.92%
-1.29B
3.03%
income before tax
3.27B
-
1.25B
61.86%
3.07B
146.31%
3.55B
15.74%
2.23B
37.30%
1.99B
10.51%
1.55B
22.33%
3.92B
152.97%
-265M
106.77%
2.50B
1,043.77%
6.90B
175.85%
income tax expense
696M
-
11M
98.42%
243M
2,109.09%
146M
39.92%
-641M
539.04%
-57M
91.11%
321M
663.16%
772M
140.50%
-380M
149.22%
-792M
108.42%
938M
218.43%
net income
2.56B
-
1.23B
51.76%
2.83B
129.12%
3.50B
23.86%
3.00B
14.23%
2.15B
28.19%
1.33B
38.05%
3.20B
139.40%
112M
96.50%
3.29B
2,835.71%
5.96B
81.11%
weighted average shs out
1.25B
-
1.26B
0.80%
1.26B
0.16%
1.26B
0.08%
1.27B
0.08%
1.27B
0.08%
1.30B
2.68%
1.31B
0.85%
1.42B
8.08%
1.55B
9.17%
1.55B
0.06%
weighted average shs out dil
1.25B
-
1.26B
0.80%
1.26B
0.08%
1.27B
0.08%
1.27B
0.08%
1.27B
0%
1.30B
2.68%
1.31B
0.92%
1.43B
8.68%
1.56B
9.32%
1.56B
0.13%
eps
2.04
-
0.98
51.96%
2.23
127.55%
2.77
24.22%
2.37
14.44%
1.70
28.27%
1.03
39.41%
2.44
136.89%
0.08
96.72%
2.12
2,550%
3.84
81.13%
epsdiluted
2.04
-
0.98
51.96%
2.23
127.55%
2.76
23.77%
2.37
14.13%
1.70
28.27%
1.03
39.41%
2.44
136.89%
0.08
96.72%
2.11
2,537.50%
3.81
80.57%

All numbers in GBP (except ratios and percentages)